Ambu A/S

TRANSACTIONS UNDER AMBU’S SHARE BUYBACK PROGRAM

2.2.2026 08:44:42 CET | Ambu A/S | Changes in company's own shares

On 10 December 2025, Ambu announced a share buyback program (company announcement no. 7 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                            

During the program, Ambu will repurchase shares for a total amount of up to DKK 150m from 10 December 2025 until no later than 31 March 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 26 January to 30 January 2026:

 

 

Number of shares

Average purchase price, DKK

Transaction value, DKK

Accumulated under the program after last announcement

1,034,445

86.5836

 89,565,949

2026.01.26

2,564

86.3954

 221,518

2026.01.27

100,000

86.1475

 8,614,750

2026.01.28

190,000

85.4863

 16,242,397

2026.01.29

146,111

84.9017

 12,405,072

2026.01.30

2,150

84.6820

 182,066

Accumulated under the program

1,475,270

86.2430

127,231,753

After the above mentioned transactions DKK 22,768,247 remains to be repurchased. Ambu now owns 3,924,394 treasury shares, corresponding to 1.5% of the share capital.

Contacts

Anders Hjort

Head of Investor Relations

anhj@ambu.com

Tine Bjørn Schmidt

Director of Corporate Communications

tisc@ambu.com

About Ambu A/S

Ever since 1937, Ambu has surpassed expectations with groundbreaking solutions that improve patient care. Millions of patients, clinicians, and health systems worldwide rely on our endoscopy, anesthesia, and patient monitoring solutions for efficiency, safety, and performance. Our ownership of every stage of the product life cycle enables us to work closely with healthcare professionals, maintain a reliable product supply, and uphold full transparency. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, and the Asia Pacific, 5,200+ Ambu team members are committed to delivering above and beyond.

Attachments

Subscribe to our company announcements

Keep up to date with our company announcements by subscribing.

Visit our pressroom and see more company announcements from us.

Our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye